Upadhayay Aditya, Ling Jingjing, Pal Dharm, Xie Yuhao, Ping Feng-Feng, Kumar Awanish
Department of Biotechnology, National Institute of Technology, Raipur 492010, CG, India.
Department of Good Clinical Practice, The Affiliated Wuxi Children's Hospital of Nanjing Medical University, 299 Qingyang Road, Wuxi 214023, China.
Drug Resist Updat. 2023 Jan;66:100890. doi: 10.1016/j.drup.2022.100890. Epub 2022 Nov 17.
Drug resistance is well-defined as a serious problem in our living world. To survive, microbes develop defense strategies against antimicrobial drugs. Drugs exhibit less or no effective results against microbes after the emergence of resistance because they are unable to cross the microbial membrane, in order to alter enzymatic systems, and/or upregulate efflux pumps, etc. Drug resistance issues can be addressed effectively if a "Resistance-Proof" or "Resistance-Resistant" antimicrobial agent is developed. This article discusses first the need for resistance-proof drugs, the imminent properties of resistance-proof drugs, current and future research progress in the discovery of resistance-proof antimicrobials, the inherent challenges, and opportunities. A molecule having imminent resistance-proof properties could target microbes efficiently, increase potency, and rule out the possibility of early resistance. This review triggers the scientific community to think about how an upsurge in drug resistance can be averted and emphasizes the discussion on the development of next-generation antimicrobials that will provide a novel effective solution to combat the global problem of drug resistance. Hence, resistance-proof drug development is not just a requirement but rather a compulsion in the drug discovery field so that resistance can be battled effectively. We discuss several properties of resistance-proof drugs which could initiate new ways of thinking about next-generation antimicrobials to resolve the drug resistance problem. This article sheds light on the issues of drug resistance and discusses solutions in terms of the resistance-proof properties of a molecule. In summary, the article is a foundation to break new ground in the development of resistance-proof therapeutics in the field of infection biology.
耐药性在我们的生物界中被明确认定为一个严重问题。为了生存,微生物会形成对抗菌药物的防御策略。耐药性出现后,药物对微生物的效果会降低或完全无效,因为它们无法穿过微生物膜、改变酶系统和/或上调外排泵等。如果能开发出一种“抗耐药性”或“耐抗性”抗菌剂,耐药性问题就能得到有效解决。本文首先讨论了对抗耐药性药物的需求、抗耐药性药物应具备的特性、抗耐药性抗菌剂发现方面的当前和未来研究进展、固有的挑战以及机遇。具有抗耐药性特性的分子可以有效地靶向微生物、提高效力并排除早期耐药性的可能性。这篇综述促使科学界思考如何避免耐药性的激增,并强调了关于开发下一代抗菌剂的讨论,这些抗菌剂将为应对全球耐药性问题提供一种新的有效解决方案。因此,开发抗耐药性药物不仅是药物发现领域的一项要求,更是一种迫切需求,以便能够有效地对抗耐药性。我们讨论了抗耐药性药物的几个特性,这些特性可能引发关于下一代抗菌剂的新思维方式,以解决耐药性问题。本文揭示了耐药性问题,并从分子的抗耐药性特性方面讨论了解决方案。总之,本文是在感染生物学领域开发抗耐药性治疗方法方面开创新局面的基础。